undamentalytics Newsletter

Pfizer dividend history

Pfizer's dividend was $1.72 a share in fiscal 2025, up 1.8% on the year before. That was 125.7% of net income. It has raised its dividend per share every year since fiscal 2010, as far back as our figures go.

Dividends, buybacks and capital spending

Dividends (TTM)
$9.8B
Diluted share count
+0.3%
year over year
Total shareholder yield
5.5%
dividends 5.5% + buybacks 0.0% of market value
Dividend payout ratio
243%
of net income paid out
R&D spending
18.1%
of revenue
Sales & admin spending
21.7%
of revenue
Days sales outstanding
81 days
receivables vs revenue

Dividends by fiscal year

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Pfizer: dividends by fiscal year, annual
Fiscal year2007Dec 20072008Dec 20082009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Dividend per share———$0.720$0.800$0.880$0.960$1.22$1.30$1.38$1.46$1.53$1.57$1.61$1.65$1.69$1.72—
Dividend per share growth————+11.1%+10.0%+9.1%+27.1%+6.6%+6.2%+5.8%+4.8%+2.6%+2.5%+2.5%+2.4%+1.8%—
Dividends paid8.08.55.56.16.26.56.67.37.78.08.08.48.79.09.29.59.89.8
Share buybacks10.00.50.01.09.08.216.35.05.012.28.90.00.02.00.00.0——
Dividends ÷ net income97.9%105.4%64.3%73.7%62.3%44.8%29.9%101.4%35.9%71.5%50.2%92.1%39.7%28.6%436.4%118.4%125.7%242.8%

Dividend per share is the amount declared for the fiscal year as stated in the company's filings (including any special dividend), restated for stock splits and checked against the cash dividends paid. Dividends paid and buybacks are cash amounts; the last-twelve-months column can include an extra payment when a quarter-end date moves.

Recent dividend announcements

  • Pfizer board approves Q4 2026 dividend Source

Compare with peers

Head to head: MRK vs PFEAZN vs PFEBMY vs PFELLY vs PFE

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Pfizer's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pfizer.